| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $409.2M | +4.7% | +105.5% |
| R&D Expense | $25.1M | -2.1% | +94.7% |
| SG&A Expense | $57.5M | -0.0% | +24.8% |
| Operating Income | $42.2M | +11.9% | +363.5% |
| Pre-tax Income | $1.8M | +124.6% | +122.2% |
| Income Tax | -$798K | +89.5% | -202.0% |
| Net Income | $2.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $216.8M | +17.7% | -29.5% |
| Accounts Receivable | $291.0M | +2.8% | +103.5% |
| Current Assets | $542.4M | +7.9% | +16.2% |
| Total Assets | $3.86B | -0.4% | +132.7% |
| Current Liabilities | $239.8M | -5.4% | +97.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $129.2M | — | — |
| Capital Expenditures | $2.8M | — | — |
| Investing Cash Flow | -$37.3M | — | — |
| Financing Cash Flow | -$45.0M | — | — |
| Free Cash Flow | $126.3M | — | — |
| +741.9% |
| +129.3% |
| EPS (Basic) | $0.01 | — | +116.7% |
| EPS (Diluted) | $0.01 | — | +116.7% |
| $2.14B |
| -0.1% |
| +282.2% |
| Total Liabilities | $2.55B | -0.7% | +246.9% |
| Stockholders' Equity | $1.30B | +0.2% | +41.4% |